Showing 35,658 results

Filters
Side effects

Risk factors for gynaecomastia include hepatitis C, fat loss, and low testosterone

News
10 November 2004
Hepatitis & HIV

HCV co-infection hastens HIV disease progression, finds US veterans study

News
10 November 2004

Major UK HIV clinic finds one in five patients diagnosed with CD4 count below 50

News
8 November 2004
Starting treatment

Detectable viral load risk factor for new illness in those who start HAART with CD4 below 50

News
8 November 2004
Hepatitis & HIV

ICAAC: HIV / HCV coinfected patients with fibrosis get little benefit and a lot of side-effects from interferon / ribavirin

News
3 November 2004
Hepatitis & HIV

ICAAC: Pegylated interferon-alpha 2a produces good results in HIV / HCV patients with genotype 1

News
3 November 2004

An integrated approach to HIV and TB care in adults in resource-limited settings, part 1

News
3 November 2004
Chemsex & recreational drug use

ICAAC: Rapid HIV disease progression in injecting drug users in Ukraine

News
2 November 2004
People with limited treatment options

ICAAC: Tipranavir / ritonavir superior to other boosted PIs in salvage therapy

News
2 November 2004
HIV treatment

ICAAC: Kaletra: stability and potency decline rapidly in hot climates

News
2 November 2004
Starting treatment

ICAAC: Tolerability key to superior showing of tenofovir/FTC in head to head match with Combivir

News
1 November 2004
New & experimental HIV treatments

ICAAC: Glaxo unveils chemokine blocker as interest in new drug class hots up

News
1 November 2004
Starting treatment

US HIV treatment guidelines revised

News
1 November 2004
People with limited treatment options

ICAAC: When to use T-20: new analysis shows risk of leaving it too late

News
31 October 2004
Resistance

ICAAC: Resistance found in one in seven of treatment-naive US patients

News
31 October 2004

ICAAC: Kaletra exposure decreased by tenofovir in experienced HIV patients

News
31 October 2004

ICAAC: Saquinavir and ritonavir must be taken simultaneously for best saquinavir levels

News
31 October 2004
Changing treatment

ICAAC: Tenofovir and Trizivir effective and well-tolerated in patients who fail first regimen

News
31 October 2004
Starting treatment

ICAAC: Combination of tenofovir and Trizivir as effective and tolerable as Combivir / efavirenz

News
31 October 2004
Side effects

ICAAC: Fall in immune cells predicts reaction to abacavir, and high incidence of reaction if abacavir used during primary infection

News
30 October 2004

ICAAC: African-Americans less likely to experience immunologic failure when taking efavirenz

News
30 October 2004
Treatment interruptions

ICAAC: Treatment breaks riskier if NNRTIs involved

News
30 October 2004
How HIV works

ICAAC: Men shed HIV in sexual fluids more often than women

News
30 October 2004
Testing & health monitoring

ICAAC: Mitochondrial DNA level in blood may provide early warning of lipodystrophy

News
30 October 2004